Transforming Thalassemia Treatment with PK Activation
About
A CME accredited webinar exploring emerging evidence and clinical insights on PK activation as a novel therapeutic approach in the management of thalassemia.
When
Friday, May 15, 2026 · 8:00 p.m.
+04 (GMT +4:00)
Agenda
8:00 - 8:05 PM - Opening Remarks - Dr. Asma Al Olama
8:05 - 8:30 PM - Thalassemia: From Supportive care to Targeting the root cause - Prof. Ali Taher
8:05 - 8:30 PM - ENERGIZE/T Revolutionizing Patient Care - Prof. Khaled Musallam
8:30 - 8:45 PM - Role of MDT in Optimizing Patient Care: A view from the Dubai Eye - Prof. Hany Dewedar
8:45 - 9:05 PM - TDT/NTDT Challenging Cases - Dr. Amar Lal & Dr. Mozah Al Marshoodi
9:05 - 9:25 PM - Panel Discussion - All Faculty
9:30 PM - Closing Remarks - Dr. Asma Al Olama
Presenters
Dr. Asma Al Olama
Chairperson
President,
Emirates Society of Haematology
Consultant Hematologist
Dubai Hospital
UAE
Prof. Ali Taher
Speaker
Professor of Medicine in Hematology &
Oncology at the American University of
Beirut Medical Center
Director of Naef K. Basile Cancer Institute,
and Associate VP for Academic Centers
Lebanon
medULive uses cookies to ensure the security of your session, support CME attendance verification, and improve your experience. By clicking "Accept", you consent to our use of cookies in accordance with our Cookie Policy and the UAE Personal Data Protection Law (PDPL). You may decline non-essential cookies — this will not affect your CME credit eligibility.